kras mutation and glutathion Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation the Potential of Immunotherapy KRAS in Non-Small Cell Lung
KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports What should we know about the 'undruggable' target KRAS? MedChemExpress KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




